Skip to main content

Table 1 Patient characteristics

From: Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring

Characteristic

TDM patients N= 618

Age (years)*

84 (24–99)

P-creatinine (mmol/L)*

100 (36–598)

Daily digoxin dose (mg)*

0.13 (0.04–0.5)

Concomitant drugs*

5 (1–21)

Patients below therapeutic range (< 1.2 nmol/L)

263

Patients within therapeutic range (1.2–2.5 nmol/L)

317

Patients above therapeutic range (> 2.5 nmol/L)

38

  1. *Median (range). TDM = therapeutic drug monitoring.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us